Osteogenesis imperfecta (OI) is a phenotypically and genetically heterogeneous connective tissue disorder characterized by symptoms such as a high frequency of fractures, bone deformities, growth deficiency, blue sclerae, hearing loss, and decreased pulmonary function. The Sillence classification system divides OI into four types (I [mild], II [lethal], III [severe], and IV [moderate]) based on its clinical and radiographic features1. Severe OI may also involve hydrocephalus;2howe...